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caid et al. showed that the TTV encodes a miRNA in vivo thatorque teno virus (TTV) is a non-enveloped human DNA virus
solated by Nishizawa et al. in 1997.1 TTV, recently classiﬁed
s the Alphatorquevirus genus within the Anelloviridae family by
he International Committee on Taxonomy of Viruses (ICTV),
as the ﬁrst human virus with a single-stranded circular DNA
enome to be identiﬁed.2 Thus far, ﬁve main genetic groups
Groups 1–5) involving at least 39 genotypes have been identi-
ed based on phylogenetic analysis.3
The TTV genome can be divided into an untranslated
egion (UTR) of 1.2 kb and a potential coding region of 2.6 kb.
he UTR is relatively conserved, suggesting that it plays
n important regulatory role in viral replication. The cod-
ng region contains two large open reading frames: ORF1 and
RF2. Several other open reading frames have been described,
nd the peptides that they encode differ in length for different
solates.4
This virus is characterized by an extremely high preva-
ence, with relatively uniform distribution worldwide and a
igh level of genomic heterogeneity.4 Although this virus
as a very high prevalence in the general population across
he globe, neither its interaction with its hosts nor its direct
nvolvement in the etiology of speciﬁc diseases is fully under-
tood.
After the discovery of TTV, its detection has been by
olymerase chain reaction (PCR) with primers targeting the
RF1 (N22 region, the ﬁrst described sequence), nevertheless
rimers derived from the N22 region can detect only a portion
f TTV variants mainly representing genetic group 1 TTV
5,6Genotypes 1–6). As the UTRs of the viral genome are more
onserved when compared to the ORF regions, UTR-targeting
rimers (used later for the detection of TTV DNA) can detect
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eserved.essentially all known TTV strains reported, thereby detecting a
larger number of genotypes giving a higher detection rate.5,7,8
In this issue of the Revista Brasileira de Hematologia e
Hemoterapia, there is an important study entitled “Preva-
lence of Torque teno virus in healthy donors of Paraná State,
southern Brazil”. In this article, the authors demonstrated the
prevalence of the TTV in healthy donors in the northern and
northwestern regions of the state of Paraná, southern Brazil,
by nested PCR using a set of primers for the N22 region.9
The authors demonstrated a high prevalence of TTV (69%)
among healthy blood donors by using primers targeting the
N22 region. It is therefore possible that if the authors had used
primers for the UTRs the prevalence would have been even
higher.
This high prevalence of the virus makes it almost ubiq-
uitous in the human population and able to evade clearance
by the host immune response thereby establishing long-
term persistent infections.10 In this context we  can highlight
the MicroRNAs (miRNAs), small 22 nt noncoding RNAs that
direct posttranscriptional gene regulation, that have been
recognized as important regulators of gene expression in
many eukaryotes and even in viruses.11 Emerging themes
of viral miRNA function include immune evasion, prolong-
ing longevity of host cells, and regulation of persistent
infection.12–14
The TTV makes use of viral miRNAs to modulate the
innate immune response and promote its persistence. Kin-
15):336–40.
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targets N-myc (and STAT) interactor (NMI), thus mediating a
decreased response to interferons and increased cellular pro-
liferation in the presence of interferon. These facts support the
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theory that miRNA-mediated immune evasion contributes to
the immense ubiquity of these viruses by antagonizing the
host antiviral response.
It has been suggested that TTV infection is associated with
many diseases, however there is no direct evidence of links
between infection and speciﬁc clinical diseases, and many
questions remain to be clariﬁed for example, how can TTV
interfere in many  pathological processes and in the dysregu-
lation of the immune system? These questions undoubtedly
represent rich ﬁelds for research on TTV.
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